|
× |
 |
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin PDF |
$40.00 |
|
$40.00 |
|
× |
|
Occurrence and Clinical Correlates of Psychiatric Comorbidity in Patients With Psychotic Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Insomnia and Impaired Quality of Life in the United States PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial PDF |
$40.00 |
|
$40.00 |
|
|
